Претраживање
Приказ резултата 1-7 од 7
ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis
(Frontiers Media S.A., 2021)
Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.
(Frontiers in Immunology, 2019)
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
(Frontiers in Immunology, 2021)
Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
(Frontiers in Immunology, 2018)
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.
(Frontiers in Immunology, 2018)
Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice.
(Frontiers in Immunology, 2019)
ILC3: a case of conflicted identity
(Lausanne: Frontiers Media SA, 2023)